Drugs / PF-04455242
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT00988949 | Nov → Dec 2009 | bipolar depression | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT00939887 | Sep → Dec 2009 | bipolar disorder, depressive disorder | Pfizer | Terminated | No outcome recorded |
| Phase 1 | NCT00956956 | Sep → Dec 2009 | — | Pfizer | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00938301 Comparator | Apr → Jul 2009 | bipolar depression | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-04455242 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00939887 ↗ |
| Modality | Small molecule | — CHEMBL1818341 ↗ |
| Route | Oral | “PF-04455242 administered orally to healthy adult subjects” NCT00956956 ↗ |